More articles from Contributions

  • Cardiac rhythm and conduction disturbances in patients undergoing mitral valve surgery
    George K. Brodell, MD, Delos Cosgrove, MD, William Schiavone, DO, Donald A. Underwood, MD and Floyd D. Loop, MD
    Cleveland Clinic Journal of Medicine September 1991, 58 (5) 397-399;

    Mitral valve replacement and repair were compared as to their effect on the incidence of supraventricular rhythm and conduction disturbances in a group of patients with isolated mitral valve disease.

  • Eosinophilia-myalgia syndrome: the Cleveland Clinic experience
    Holly L. Thacker, MD
    Cleveland Clinic Journal of Medicine September 1991, 58 (5) 400-408;

    Significant nerve and muscle involvement, diffuse fasciitis, and weight loss were adverse prognosticating factors in this group of patients. Those who survived the acute phase and stabilized were more likely to continue to improve.

  • Transesophageal echocardiography in the critical care unit
    Vicente E. Font, MD, Timothy P. Obarski, DO, Allan L. Klein, MD, James C. Bartlett, DO, James J. Nemec, MD, William J. Stewart, MD and Ernesto E. Salcedo, MD
    Cleveland Clinic Journal of Medicine July 1991, 58 (4) 315-322;

    Transesophageal echocardiography can provide a new acoustic window to the heart in critically ill patients, offering improved identification of cardiac abnormalities.

  • Atrial fibrillation and flutter with left bundle branch block aberration referred as ventricular tachycardia
    Richard G. Trohman, MD, Kenneth M. Kessler, MD, Deborah Williams, MD and James D. Maloney, MD
    Cleveland Clinic Journal of Medicine July 1991, 58 (4) 325-330;

    Ventricular tachycardia, a potentially lethal arrhythmia, may be difficult to differentiate from supraventricular tachycardia with aberration. Electrophysiologic testing helps the clinician identify the origin of the arrhythmia, assess long-term prognosis, and choose appropriate therapy.

  • Transcatheter electrical AV junction ablation: predictors of success
    Tony W. Simmons, MD, Hassan M.K. Nagi, MD, Bruce L. Wilkoff, MD, Victor A. Morant, MD, Richard Sterba, MD, Lon W. Castle, MD and James D. Maloney, MD
    Cleveland Clinic Journal of Medicine May 1991, 58 (3) 223-228;

    Factors influencing transcatheter ablation outcome were analyzed in 29 patients unresponsive to drug therapy.

  • Prophylaxis and treatment of post-renal transplant rejection
    Donald R. Steinmuller, MD, Ernest Hodge, MD, Christopher Boshkos, MD, Stevan B. Streem, MD, Andrew C. Novick, MD and Dawn Bailey, RN
    Cleveland Clinic Journal of Medicine March 1991, 58 (2) 125-130;

    Monoclonal preparations offer advantages over polyclonal preparations in the prophylaxis and treatment of post-transplant rejection in renal transplantation.

  • The Telelab personal blood pressure transmitter: accurate and reliable home monitoring for hypertensive patients
    Donald G. Vidt, MD, Kennith Bolen, Ray W. Gifford, MD and Sharon Vanderbrug Medendorp
    Cleveland Clinic Journal of Medicine January 1991, 58 (1) 28-32;

    A home blood pressure recording device that can transmit data by phone is accurate and convenient.

  • Risk factors for in-hospital mortality associated with coronary angioplasty
    Conrad Simpfendorfer, MD, Khosrow Dorosti, MD, Irving Franco, MD, Jay Hollman, MD and Patrick Whitlow, MD
    Cleveland Clinic Journal of Medicine January 1991, 58 (1) 25-27;

    Elderly women with extensive coronary disease were at higher risk of mortality than other patient groups.

  • Psychological factors in men with genital pain
    Leslie R. Schover, PhD
    Cleveland Clinic Journal of Medicine November 1990, 57 (8) 697-700;

    When organic causes of male genital pain have been ruled out, stress, inadequate social support, and psychological factors should be considered.

  • Hepatic artery infusion chemotherapy for colorectal liver metastases
    Rudolph B. Rustin, MD, David P. Vogt, MD, Ronald M. Bukowski, MD and Kirk V. Shepard, MD
    Cleveland Clinic Journal of Medicine November 1990, 57 (8) 692-696;

    The Infusaid pump was found to be a reliable system of drug delivery that may result in regression of liver metastases in some patients.

Pages